- Home
- PAVM vs CSCI Comparison
PAVM vs CSCI Comparison
Compare PAVM & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- CSCI
- Stock Information
- Founded
- PAVM 2014
- CSCI 1990
- Country
- PAVM United States
- CSCI Canada
- Employees
- PAVM N/A
- CSCI N/A
- Industry
- PAVM Medical/Dental Instruments
- CSCI
- Sector
- PAVM Health Care
- CSCI
- Exchange
- PAVM Nasdaq
- CSCI NYSE
- Market Cap
- PAVM 12.0M
- CSCI 10.6M
- IPO Year
- PAVM 2016
- CSCI 1996
- Fundamental
- Price
- PAVM $0.59
- CSCI $3.96
- Analyst Decision
- PAVM Strong Buy
- CSCI
- Analyst Count
- PAVM 1
- CSCI 0
- Target Price
- PAVM $19.00
- CSCI N/A
- AVG Volume (30 Days)
- PAVM 115.2K
- CSCI 5.2K
- Earning Date
- PAVM 08-11-2025
- CSCI 08-12-2025
- Dividend Yield
- PAVM N/A
- CSCI N/A
- EPS Growth
- PAVM N/A
- CSCI N/A
- EPS
- PAVM 0.96
- CSCI N/A
- Revenue
- PAVM $1,993,000.00
- CSCI $9,030,000.00
- Revenue This Year
- PAVM N/A
- CSCI N/A
- Revenue Next Year
- PAVM $455.63
- CSCI N/A
- P/E Ratio
- PAVM $0.62
- CSCI N/A
- Revenue Growth
- PAVM N/A
- CSCI 36.51
- 52 Week Low
- PAVM $0.54
- CSCI $1.96
- 52 Week High
- PAVM $1.90
- CSCI $6.77
- Technical
- Relative Strength Index (RSI)
- PAVM 44.90
- CSCI N/A
- Support Level
- PAVM $0.58
- CSCI N/A
- Resistance Level
- PAVM $0.62
- CSCI N/A
- Average True Range (ATR)
- PAVM 0.03
- CSCI 0.00
- MACD
- PAVM 0.00
- CSCI 0.00
- Stochastic Oscillator
- PAVM 55.90
- CSCI 0.00
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.